ACCESSION: MSBNK-SMB_Measured-HSA015P0132004
RECORD_TITLE: Characterized; Creatine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 14
COMMENT: RAW_SPEC {'EL02_pos_1191': {'bp': 1924826.0, 'sum': 3576598.0}, 'EL08_pos_1186': {'bp': 1511886.0, 'sum': 2824033.0}, 'EL01_pos_1191': {'bp': 1510004.0, 'sum': 3512449.0}, 'EL14_pos_1193': {'bp': 1445503.0, 'sum': 2824431.0}, 'EL17_pos_1185': {'bp': 1304716.0, 'sum': 3057647.0}, 'EL22_pos_1193': {'bp': 1241881.0, 'sum': 2324774.0}, 'EL20_pos_1185': {'bp': 1142322.0, 'sum': 2804621.0}, 'EL10_pos_1185': {'bp': 1029310.0, 'sum': 1874370.0}, 'EL09_pos_1187': {'bp': 965262.0, 'sum': 2088784.0}, 'EL18_pos_1186': {'bp': 963219.0, 'sum': 1970463.0}, 'EL11_pos_1186': {'bp': 925692.0, 'sum': 1706812.0}, 'EL04_pos_1197': {'bp': 881081.0, 'sum': 2058689.0}, 'EL12_pos_1186': {'bp': 852035.0, 'sum': 1701674.0}, 'EL07_pos_1185': {'bp': 844785.0, 'sum': 1742193.0}}
COMMENT: RETENTION_TIME_STDEV 0.004
COMMENT: PRECURSOR_M/Z_RAW 132.076934
COMMENT: PRECURSOR_M/Z_STDEV 0.000040
COMMENT: PRECURSOR_IN_MS1 mz 132.076719; int 19.151; delta(ppm) 0.724369
COMMENT: PROPOSED_CHARGE_STATE +1; mz 133.080061; int 1.176; cor 0.965
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+IsoProp+H; M+ACN+Na; mz 135.026162; int 0.838; cor 0.632
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.252; C4H9N3O2; [M+H]+; delta(ppm) -0.251775
COMMENT: PROPOSED_MF MS-FINDER 4.092; C4H9N3O2; [M+H]+; delta(ppm) -0.249743
COMMENT: PROPOSED_MF SIRIUS5_Sirius 14.607; C4H9N3O2; [M+H]+; delta(ppm) -0.249743
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H9N3O2; [M+H]+; delta(ppm) -0.249743
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.851; C4H9N3O2; [M+H]+; delta(ppm) -0.249743
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.600; C2H7N6O; [M+H]+; delta(ppm) 9.916141
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.816; C6H11O3; [M+H]+; delta(ppm) -10.415420
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H9N3O2; [M+H]+; delta(ppm) -0.249743
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; CVSVTCORWBXHQV-UHFFFAOYSA-N; C4H9N3O2; ReSpect:PT201840 Creatine,anhydrousN-Amidinosarcosine(alpha-Methylguanido)acetic acidKrebiozonMethyl Glycocyaminealpha-Methylguanidinoacetic Acid2-(carbamimidoyl-methylamino)acetic acid
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; KMXXSJLYVJEBHI-UHFFFAOYSA-N; C4H9N3O2; ReSpect:PT203830 3-Guanidinopropionic acid3-Guanidinopropanoatebeta-Guanidinopropionic acid3-Guanidinopropanoic acidN-(Aminomethyl)-beta-alanine3-(diaminomethylideneamino)propanoic acid
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.686; DVNFLGLGNLXITH-UHFFFAOYSA-N; [M+H]+; O=C(O)C(NC(=N)N)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.682; CVSVTCORWBXHQV-UHFFFAOYSA-N; [M+H]+; CN(CC(O)=O)C(N)=N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.682; VTYMULRIBAMCLK-UHFFFAOYSA-N; [M+H]+; O=C(N)C(=O)NCCN
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.530; KMXXSJLYVJEBHI-UHFFFAOYSA-N; [M+H]+; NC(=N)NCCC(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.517; DSLBDPPHINVUID-REOHCLBHSA-N; [M+H]+; C(C(C(=O)N)N)C(=O)N
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.789; CVSVTCORWBXHQV-UHFFFAOYSA-N; [M+H]+; Creatine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.120; KMXXSJLYVJEBHI-UHFFFAOYSA-N; [M+H]+; Beta-Guanidinopropionic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.008; HQAXXRWVFPWZIL-ALCCZGGFSA-N; [M+H]+; UNPD163851
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.967; WXOFJMWQRNARBH-UHFFFAOYSA-N; [M+H]+; 2-[diaminomethylene(methyl)ammonio]acetate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.915; BYUOAQWHIKQRNX-UHFFFAOYSA-N; [M+H]+; methyl 2-(diaminomethylideneamino)acetate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.903; YGGSSUISOYLCBF-UHFFFAOYSA-N; [M+H]+; 1-nitroso-1-propylurea
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.903; VTYMULRIBAMCLK-UHFFFAOYSA-N; [M+H]+; CNP0447118
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.898; DVNFLGLGNLXITH-UHFFFAOYSA-N; [M+H]+; N-Amidinoalanine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.880; KUGBOAOPCUFIJN-UHFFFAOYSA-N; [M+H]+; (diaminomethylideneamino) propanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.811; DSLBDPPHINVUID-REOHCLBHSA-N; [M+H]+; (2S)-2-aminobutanediamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.811; HQETVJNRDIVRPA-UHFFFAOYSA-N; [M+H]+; 3-(N'-aminomethanimidamido)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; KUGBOAOPCUFIJN-UHFFFAOYSA-N; [M+H]+; (diaminomethylideneamino) propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.927; YGGSSUISOYLCBF-UHFFFAOYSA-N; [M+H]+; 1-nitroso-1-propylurea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.923; VTYMULRIBAMCLK-UHFFFAOYSA-N; [M+H]+; CNP0447118
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.917; HQAXXRWVFPWZIL-ALCCZGGFSA-N; [M+H]+; UNPD163851
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.497; BYUOAQWHIKQRNX-UHFFFAOYSA-N; [M+H]+; methyl 2-(diaminomethylideneamino)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.447; CVSVTCORWBXHQV-UHFFFAOYSA-N; [M+H]+; Creatine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.447; KMXXSJLYVJEBHI-UHFFFAOYSA-N; [M+H]+; Beta-Guanidinopropionic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.447; WXOFJMWQRNARBH-UHFFFAOYSA-N; [M+H]+; 2-[diaminomethylene(methyl)ammonio]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.447; DVNFLGLGNLXITH-UHFFFAOYSA-N; [M+H]+; N-Amidinoalanine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.077; DSLBDPPHINVUID-REOHCLBHSA-N; [M+H]+; (2S)-2-aminobutanediamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; HQETVJNRDIVRPA-UHFFFAOYSA-N; [M+H]+; 3-(N'-aminomethanimidamido)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.482; CVSVTCORWBXHQV-UHFFFAOYSA-N; [M+H]+; 2-[carbamimidoyl(methyl)amino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.335; YGGSSUISOYLCBF-UHFFFAOYSA-N; [M+H]+; 1-nitroso-1-propylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.096; LOEHVDVYTQIWEV-UHFFFAOYSA-N; [M+H]+; 1,1,3-trimethyl-3-nitrosourea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.087; KMXXSJLYVJEBHI-UHFFFAOYSA-N; [M+H]+; 3-(diaminomethylideneamino)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.842; MQLQMSXXDOSWKY-UHFFFAOYSA-N; [M+H]+; 1-ethyl-3-methyl-1-nitrosourea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.842; IHSMGJQJILYALZ-UHFFFAOYSA-N; [M+H]+; 3-ethyl-1-methyl-1-nitrosourea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.775; VQBVPDAUEBSGMB-UHFFFAOYSA-N; [M+H]+; 1-N,1-N'-dimethyl-2-nitroethene-1,1-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.763; YALSARYKNGABLL-UHFFFAOYSA-N; [M+H]+; ethyl 2-(aminohydrazinylidene)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.610; DVNFLGLGNLXITH-REOHCLBHSA-N; [M+H]+; (2S)-2-(diaminomethylideneamino)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.195; HGMBEFYZNDKFQJ-UHFFFAOYSA-N; [M+H]+; 2-[(2-amino-2-oxoethyl)amino]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.175; CGJFKQFYZOARRV-UHFFFAOYSA-N; [M+H]+; 2-(2-azidoethoxy)ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -14.124; CVSVTCORWBXHQV; [M+H]+; creatine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -64.175; DVNFLGLGNLXITH; [M+H]+; NCIStruc1_001820
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -78.193; KMXXSJLYVJEBHI; [M+H]+; beta-GPA
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -89.275; WXOFJMWQRNARBH; [M+H]+; methylguanidinoacetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -151.776; HGMBEFYZNDKFQJ; [M+H]+; Acetamide, 2,2''-iminobis-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -176.201; HQAXXRWVFPWZIL; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -179.413; IHSMGJQJILYALZ; [M+H]+; 1-Nitroso-1-methyl-3-ethylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.618; LOEHVDVYTQIWEV; [M+H]+; Nitrosotrimethylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -193.286; VTYMULRIBAMCLK; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -207.371; YGGSSUISOYLCBF; [M+H]+; Nitrosopropylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -210.328; DSLBDPPHINVUID; [M+H]+; Aspartamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -219.848; VQBVPDAUEBSGMB; [M+H]+; 1,1-Ethenediamine, N,N''-dimethyl-2-nitro-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -222.309; MQLQMSXXDOSWKY; [M+H]+; 1-ethyl-3-methyl-1-nitrosourea
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.675; CVSVTCORWBXHQV; [M+H]+; creatine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -14.010; CVSVTCORWBXHQV; [M+H]+; Creatin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -58.577; WXOFJMWQRNARBH; [M+H]+; {[Amino(iminio)methyl](methyl)amino}acetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -63.913; BYUOAQWHIKQRNX; [M+H]+; Methyl 2-guanidinoacetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -75.235; DVNFLGLGNLXITH; [M+H]+; N-Amidinoalanine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -93.684; KMXXSJLYVJEBHI; [M+H]+; 3-carbamimidamidopropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -106.079; KUGBOAOPCUFIJN; [M+H]+; Guanidinopropionate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -130.434; HQAXXRWVFPWZIL; [M+H]+; Lyophyllin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -134.737; CGJFKQFYZOARRV; [M+H]+; 2-(2-Azidoethoxy)ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -142.963; HGMBEFYZNDKFQJ; [M+H]+; Bis(2-amino-2-oxoethyl)azanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -143.245; LOEHVDVYTQIWEV; [M+H]+; Trimethylnitrosourea
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.878; CVSVTCORWBXHQV; [M+H]+; Creatin
COMMENT: CONFIDENCE Level 3: Tentative candidate, Creatine, CVSVTCORWBXHQV-UHFFFAOYSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (2), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (6), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0000064;
CH$NAME: Creatine
CH$NAME: 2-[carbamimidoyl(methyl)amino]acetic acid
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C4H9N3O2
CH$EXACT_MASS: 131.069477
CH$SMILES: CN(CC(=O)O)C(=N)N
CH$IUPAC: InChI=1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9)
CH$LINK: CHEBI CHEBI:16919
CH$LINK: HMDB HMDB0000064
CH$LINK: INCHIKEY CVSVTCORWBXHQV-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:586
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 1.912
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 132.076720
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-9100000000-e38d70ab19153fa6cdbc
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  58.9952507 82.3877 58.995974 0.4577 4.90 0.5209 14 ?
  61.0108408 28.4252 61.011571 0.9998 5.26 0.5033 14 ?
  76.0216659 10.6174 76.022404 1.4864 1.72 0.4818 11 ?
  86.9899620 37.8058 86.990664 0.8622 3.88 0.5385 14 ?
  87.0552888 19.6562 87.055991 0.8730 7.64 0.7967 13 f{C3H7N2O1}/-0.01ppm,p-C1H3N1O1
  88.0215893 999.0000 88.022286 0.3408 0.00 0.6308 14 ?
  90.0549786 395.7170 90.055664 0.3220 142.34 0.9912 14 f{C3H8N1O2}/0.26ppm,p-C1H2N2
  90.9032951 21.9535 90.903976 0.8581 8.09 -0.1868 14 ?
  105.0005147 29.3457 105.001079 1.2000 2.50 0.5495 13 ?
  105.0699745 13.0020 105.070538 1.1992 3.42 0.3636 12 ?
  130.9819985 19.6024 130.982322 1.2063 3.71 0.3545 11 ?
  132.0767654 149.9811 132.077076 0.6209 56.49 1.0000 14 f{C4H10N3O2}/0.09ppm,p
  134.0270978 100.3446 134.027384 0.5297 5.91 0.6264 14 ?
PK$NUM_PEAK: 13
PK$PEAK: m/z int. rel.int.
  58.995251 82.39 82
  61.010841 28.43 28
  76.021666 10.62 10
  86.989962 37.81 37
  87.055289 19.66 19
  88.021589 999.00 999
  90.054979 395.72 395
  90.903295 21.95 21
  105.000515 29.35 29
  105.069974 13.00 13
  130.981999 19.60 19
  132.076765 149.98 149
  134.027098 100.34 100
//
